Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons
- Supplementary File 1:
PDF-Document (PDF, 425 KiB)
Chandrasekaran, K.; Choi, J.; Arvas, M.I.; Salimian, M.; Singh, S.; Xu, S.; Gullapalli, R.P.; Kristian, T.; Russell, J.W. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. Int. J. Mol. Sci. 2020, 21, 3756. https://doi.org/10.3390/ijms21113756
Chandrasekaran K, Choi J, Arvas MI, Salimian M, Singh S, Xu S, Gullapalli RP, Kristian T, Russell JW. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. International Journal of Molecular Sciences. 2020; 21(11):3756. https://doi.org/10.3390/ijms21113756
Chicago/Turabian StyleChandrasekaran, Krish, Joungil Choi, Muhammed I. Arvas, Mohammad Salimian, Sujal Singh, Su Xu, Rao P. Gullapalli, Tibor Kristian, and James W. Russell. 2020. "Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons" International Journal of Molecular Sciences 21, no. 11: 3756. https://doi.org/10.3390/ijms21113756